Purpose The pharmacology, pharmacokinetics, efficacy, and safety of apixaban are reviewed. Summary Apixaban is an oral, direct, selective factor Xa inhibitor with a rapid onset of action.
In this randomized controlled trial, among patients with atrial fibrillation requiring anticoagulation therapy, asundexian ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback